| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/08/2008 | US20080108702 Use of Acetyl-Leucine for Preparing a Drug for Treating Balance Disorders |
| 05/08/2008 | US20080108701 Diagnostic Agent for Tumor |
| 05/08/2008 | US20080108700 Comprises a topical anesthetic (lidocaine) and a mast cell degranulation inhibitor (tranilast); photostability; enhanced transdermal penetration |
| 05/08/2008 | US20080108699 Composition Comprising Dihomo-y-Linolenic Acid (Dgla) As Active Ingredient |
| 05/08/2008 | US20080108698 Nutrient Supplement and Use of the Same |
| 05/08/2008 | US20080108697 Using a glass bottle containing oxaliplatin in aqueous solution at a concentration between 2 mg/ml and 7 mg/ml; metastatic colorectal cancers; surface/volume ratio of the flask, expressed in mm2/mm3, is less than 0.26 |
| 05/08/2008 | US20080108696 Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases |
| 05/08/2008 | US20080108695 5,6,7-trihydroxyheptanoic acid and its analogs ; allergic dermatitis, contact hypersensitivity, urticaria (hives), rosacea, or psoriasis |
| 05/08/2008 | US20080108694 Inhibit the growth of or kill Rb negative cancer cells; inhibit the activity of Heat shock protein 90; antibiotics, antimalarial agents, anticancer agents, antitumor agents; cytotoxicity; to treat glioblastoma, lung cancer and retinoblastoma |
| 05/08/2008 | US20080108693 N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol; antitumor activity; chemical stability |
| 05/08/2008 | US20080108692 Alkylene selenocyanate or an alkylene isoselenocyanate moiety; anticancer agents; food supplements; 1,4-phenylenebis(alkylene)selenocyanate |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108690 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one |
| 05/08/2008 | US20080108689 Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists |
| 05/08/2008 | US20080108688 Used for hypertension, heart failure, stroke, myocardial infarction, diabetes and cardiovascular disease; stabilized to control degradation to the active metabolite ramiprilat instead of ramipril diketopiperazine |
| 05/08/2008 | US20080108687 Ramipril formulation |
| 05/08/2008 | US20080108685 Novel Use for Alpha Sympathomimetics Having a 2-Imidazoline Structure |
| 05/08/2008 | US20080108684 Therapeutic agent for inflammatory bowel disease and tnf-alfa production inhibitor |
| 05/08/2008 | US20080108683 4-phenylthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |
| 05/08/2008 | US20080108682 reaction of R-(-)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-ethanol with 7-chloro benzothiaphene derivatives to give highly purified R-(-)-sertaconazole mononitrate hemiacetonate or R-(-)-sertaconazole mononitrate; infections caused by fungi and yeasts; higher yield; low cost |
| 05/08/2008 | US20080108681 Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions |
| 05/08/2008 | US20080108679 Isoxazolic Derivative to Relieve Neuropathic Pain |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108677 Thioxothiazolidinone Compounds For Use As Pharmaceuticals |
| 05/08/2008 | US20080108676 Benzothiazolecarboxamides |
| 05/08/2008 | US20080108675 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |
| 05/08/2008 | US20080108674 Comprising a micellular complex consisting of a cationic excipient, an anionic dye and a cationic antiseptic |
| 05/08/2008 | US20080108673 Prevention and Treatment of Obesity |
| 05/08/2008 | US20080108672 Inorganic or organic acid salts or basic salts of N-methylcarbamoylphenoxy and N-methylcarbamoylpyridyloxy-substituted diphenylureas; N-(2-methoxy-5-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea tosylate; carcinoma of the lung, pancreas, thyroid, bladder or colon. |
| 05/08/2008 | US20080108671 Non-systemic control of parasites |
| 05/08/2008 | US20080108670 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 05/08/2008 | US20080108669 Use 541 |
| 05/08/2008 | US20080108668 compounds with biological activity against all sorts of plant diseases and insects at very low dosage, to control plant diseases like cucumber downy mildew, cucumber grey mold, cucumber powdery mildew, tomato early blight, tomato late blight, phytophthora blight of pepper, grape downy mildew and etc |
| 05/08/2008 | US20080108667 [(5,6-dichloropyridin-3-yl)methyl](methyl)-oxido lambda 4-sulfanylidenecyanamide; Insecticides; potentiation; atypical mode of action; effective control in agricultural, urban and/or animal health systems by applying to a locus; control of foliar-feeding insects; aphids and other sucking insects |
| 05/08/2008 | US20080108664 Antiangiogenic; N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide (AMG 706) |
| 05/08/2008 | US20080108663 Cyclopropyl Piperidine Glycine Transporter Inhibitors |
| 05/08/2008 | US20080108662 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 05/08/2008 | US20080108661 N-{3-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-2-hydroxypropyl}-2,3-dihydro-2-oxo-4-(trifluoromethyl)-5-thiazolecarboxamide; chemokine receptor CCR3 modulator and histamin receptor H1 antagonist; antiinflammatory agent, antiallergen; asthma, rhinitis, COPD, osteoarthritis or osteoarthrosis |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108659 Poly(adp-ribose)polymerase inhibitors |
| 05/08/2008 | US20080108658 Methods of promoting osteogenesis |
| 05/08/2008 | US20080108657 Used to treat cancer including leukemia, mesothelioma, lung cancer, colorectal cancer, breast cancer, ovarian cancer, prostate cancer, melanoma, cancer of the uterine body and cancer of the central nervous system; nontoxic |
| 05/08/2008 | US20080108656 3-Fluoro-2-(2-methylsulfanyl-phenyl)-quinolin-4-yl]-pyridin-4-yl-amine; modulating transforming growth factor (TGF) - beta; fibroproliferative diseases or diseases associated with fibrosis; cardiovascular, urogenital and gastrointestinal disorders; antihypotensive, -arthritic agents; angioplasty |
| 05/08/2008 | US20080108655 Administering orphenadrine and chloroquine |
| 05/08/2008 | US20080108654 Protein kinase inhibitors; antitumor agents; such as 5-methyl-1-quinol-4-ylmethyl-3-(4-trifluoromethanesulfonylphenyl)imidazolidine-2,4-dione trifluoroacetate |
| 05/08/2008 | US20080108653 Tripeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108652 Acute/chronic inflammatory disease of peripheral organs and central nervous system (CNS) |
| 05/08/2008 | US20080108651 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly |
| 05/08/2008 | US20080108650 Such as 3-isobutyryl-2-isopropyl pyrazolo[1,5-a]pyridine; for treatment of Parkinson's disease, Huntington's disease, Alzheimer's disease, and schizophrenia |
| 05/08/2008 | US20080108649 Bicyclic modulators of androgen receptor function |
| 05/08/2008 | US20080108648 Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/08/2008 | US20080108647 Treatment of HIV and diseases of immune dysregulation |
| 05/08/2008 | US20080108646 9-fluoro-6,7,-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid; optically pure isomers of Nadifloxacin; bactericide; systemic or topical Gram-positive, Gram-negative bacterial, mycobacterial and nosocomlal pathogen infections |
| 05/08/2008 | US20080108645 Dihydrotetrabenazines And Pharmaceutical Compositions Containing Them |
| 05/08/2008 | US20080108644 alkaloids; anticarcinogenic, antiproliferative agent; inhibitor of cellular mitosis and cell proliferation; binding to tubulin leads to cell cycle arrest in M phase and subsequently to apoptosis; antiallergen, antiinflammatory, antidiabetic, autoimmune diseases; asthma, arthritis, Alzheimer' disease |
| 05/08/2008 | US20080108643 synergistic mixture of Memantine derivatives (5 - 20 mg per day) and dextromethorphan (15 - 30 mg); Pervasive Developmental Disorders (PDD); sensory integration problems, verbal and non-verbal communication, social interactions, and leisure or play activities; side effect reduction |
| 05/08/2008 | US20080108642 Matrine, oxymatrine, and sinomenine (hydrochloride); rheumatoid arthritis and cancer |
| 05/08/2008 | US20080108641 Compounds for treating inflammatory disorders, demyelinating disdorders and cancers |
| 05/08/2008 | US20080108640 Method of restoring the incretin effect |
| 05/08/2008 | US20080108638 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD |
| 05/08/2008 | US20080108637 isopropyl ester of N-(2,6-dichlorobenzoyl)-4-(6-iodo-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-3(2H)-yl)-L-phenylalanine; 4 integrin inhibitor; antiinflammatory agent; rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, asthma; preservation stability, humidity resistance or solubility; |
| 05/08/2008 | US20080108636 compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are told |
| 05/08/2008 | US20080108635 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists |
| 05/08/2008 | US20080108634 Novel phenylalanine derivatives |
| 05/08/2008 | US20080108633 Administering (S)-5-bromo-N2-(1-(5-fluoropyridin-2-yl)ethyl)-N4-(5-isopropoxy-1H-pyrazol-3-yl)pyrimidine-2,4-diamine as analgesic |
| 05/08/2008 | US20080108632 Hcv protease inhibitors |
| 05/08/2008 | US20080108631 Human protein tyrosine phosphatase inhibitors an methods of use |
| 05/08/2008 | US20080108630 Substituted triazoles as modulators of ppar and methods of their preparation |
| 05/08/2008 | US20080108629 Heterocyclic Derivatives for the Treatment of Diseases Mediated by Stearoyl-Coa Desaturase Enzymes |
| 05/08/2008 | US20080108628 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug |
| 05/08/2008 | US20080108627 9-[(3-hydroxy-5-methoxyphenyl)amino]-1,2-dihydrothieno[3,2-f]quinoline-8-carbonitrile 3,3-dioxide; protein tyrosine kinases inhibitor, especially erythropoetin-producing hepatoma amplified sequence (Eph) receptors antagonist; antitumor, angiogenesis inhibitor, neurodegenerative diseases |
| 05/08/2008 | US20080108626 (5-amino-1-phenyl-1H-pyrazole)-(3-Amino-N-isoxazol-3-yl-4-methyl)-benzamide; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 05/08/2008 | US20080108625 Substituted Triazole Derivatives as Oxytocin Antagonists |
| 05/08/2008 | US20080108624 Methylene Dipiperidine Derivatives |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108622 Administering allosteric adenosine A1 receptor enhancer in conjunction with opioid analgesics or 2-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)/kainate antagonists for alleviating postoperative pain |
| 05/08/2008 | US20080108621 Aminopterin Dosage Forms and Methods for Inflammatory Disorders |
| 05/08/2008 | US20080108620 N-(4-{(1S)-1-[3-(3,5-DICHLOROPHENYL)-5-QUINOLIN-3-YL-1H-PYRAZOL-1-YL]ETHYL}BENZOYL)- beta -ALANINE; glucagon receptor antagonists; antidiabetic agent; insulin resistance and its complications, including coronary heart disease, stroke, hypertension, nephropathy, neuropathy, retinopathy; atherosclerosis |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108618 Compounds with activity on muscarinic receptors |
| 05/08/2008 | US20080108617 Modulators of pharmacokinetic properties of therapeutics |
| 05/08/2008 | US20080108616 as serine/threonine, fusion, and tyrosine kinase receptors as nerve and fibroblast growth factor; abnormal activation of immune and nervous systems; antiproliferative; lung; 4-(3-Trifluoromethyl-phenylamino)-pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-(4-morpholin-4-yl-phenylcarbamoyl)-phenyl]-amide |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108614 Substituted 2-Amino-Quinazolin-4-Cn Compounds for Use in the Treatment of Cns Disorders, Pain, Stroke, Addiction and Epilepsy, their Preparation and Use as Intermediates |
| 05/08/2008 | US20080108613 Pyrazolopyrimidine Compounds as Antitumor Agents |
| 05/08/2008 | US20080108612 Use of Purine Derivatives as HSP90 Protein Inhibitors |
| 05/08/2008 | US20080108611 Substituted thienopyrimidine kinase inhibitors |
| 05/08/2008 | US20080108610 (4-Chloro-2-{[4-(2,4-diamino-pyrimidin-5-ylmethyl)-6,7-dimethoxy-benzofuran-2-ylmethyl]-amino}-phenyl)-pyrrolidin-1-yl-methanone; dihydrofolate reductase; bactericide; grampositive (Staphylococcus aureusand, Enterococcus faecalis) and and gramnegative pathogens (Escherichia coli, Haemophilus influenzae) |
| 05/08/2008 | US20080108609 Benzoxazole Carboxamides For Treating CINV and IBS-D |
| 05/08/2008 | US20080108608 Pyrimidines With Tie2 (Tek) Activity |
| 05/08/2008 | US20080108606 Side effect reduction; antiproliferative agents; schizophrenia |
| 05/08/2008 | US20080108605 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/08/2008 | US20080108604 sugar transport enhancement agent; antidiabetic and hypoglycemic agent; obesity, diabetic nephropathy, retinopathy, macrovascular disease, glucose tolerance anomaly; cyclization of 4-(2-aminocyclohexylamino)-3-pyrroline-2-one by aldehyde followed by acylation |
| 05/08/2008 | US20080108603 Combination therapy for the treatment of pain |
| 05/08/2008 | US20080108602 Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators |
| 05/08/2008 | US20080108599 Heterocyclic Tetracyclic Tetrahydrofuran Derivatives As 5Ht2 Inhibitors In The Treatment Of Cns Disorders |
| 05/08/2008 | US20080108598 Pharmaceutical use of substituted amides |
| 05/08/2008 | US20080108597 New Use of Quetiapine |